Jennifer Brancato Sahni, PhD

A picture of Jennifer Sahi smiling

Graduate Student

216.368.5924 (o)

I graduated from the College of the Holy Cross in 2009 where I majored in biology with a concentration in peace and conflict studies. I then moved to Philadelphia where I worked as a research assistant for three years at the University of Pennsylvania in a laboratory that studies retinal degenerative diseases. In 2012, I was accepted into the PhD program at CWRU and joined the pharmacology department. I love to travel, especially to my husband’s hometown in India.

Current Research Activities

  • Investigating the use of epigenetic modulating drugs in triple-negative breast cancer.

Professional/Volunteer Activities

  • 6/8/2015: Oral presentation, Mammary Gland Biology Gordon Conference, West Dover, VT
  • 4/24/2015: Organizer, DNA Day activities
  • 4/14/2015: Poster presentation, Cancer Genetics & Epigenetics Gordon Conference, Lucca, Italy
  • 2015–2016: President, Biomedical Graduate Student Organization (BGSO), CWRU School of Medicine, Cleveland, Ohio
  • 2014–2016: Member, CWRU Department of Pharmacology Graduate Curriculum Committee
  • 10/2013–Present: Associate Member, American Association for Cancer Research (AACR)
  • 7/2013–6/2015: Trainee, Case Comprehensive Cancer Center Cancer Biology Training Grant


  • Frost LS, Lopes VS, Bragin A, Reyes-Reveles J, Brancato J, Cohen A, Mitchell CH, Williams DS, and Boesze-Battaglia K. (2014) The contribution of melanoregulin to microtubule-associated protein 1 light chain 3 (LC3) associated phagocytosis in the retinal pigment epithelium. Mol Neurobiol. 10.1007/s12035-014-8920-5